What Is the Baby Formula NEC Lawsuit?
The Baby Formula NEC lawsuit is a group of federal and state product liability cases alleging that cow's milk-based preterm infant formula and fortifier made by Abbott Laboratories and Mead Johnson caused necrotizing enterocolitis (NEC) in premature babies. Abbott sells Similac and Mead Johnson sells Enfamil. The federal cases are centralized as MDL No. 3026, and many more are pending in state courts.
NEC is a serious intestinal disease in which tissue in the bowel wall becomes inflamed and can die. It mostly affects premature and low-birth-weight babies. Keller Postman, a plaintiffs' firm in the litigation, cites estimates that about 9,000 infants develop NEC each year in the United States and that roughly a quarter of them die.
Neither company has recalled the products. The lawsuits ask for damages and argue that the products needed stronger warnings. Abbott and Mead Johnson deny that their products cause NEC. Searchers also use "NEC" for the unrelated Form 1099-NEC tax form, which this page does not cover.
“All actions can be expected to share factual questions arising from allegations that cow's milk-based infant formula products marketed under the Similac and Enfamil brand names have a higher propensity to cause necrotizing enterocolitis (NEC) in infants born prematurely than other, allegedly safer alternatives. Although some cases are slightly advanced, we are of the opinion that the parties can obtain significant efficiencies by placing all actions before a single judge.”
Source: U.S. Judicial Panel on Multidistrict Litigation, In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation, MDL No. 3026, Transfer Order, Document 119 (April 8, 2022)
Why Are People Filing Baby Formula NEC Lawsuits?
People are filing Baby Formula NEC lawsuits because they allege that Similac and Enfamil preterm products caused their babies to develop NEC and that Abbott and Mead Johnson failed to warn parents and doctors about the risk. The claims are pled as defective design, failure to warn, negligent marketing and breach of warranty.
Plaintiffs say the companies marketed the formulas as medically endorsed and nutritionally equivalent to breast milk for the smallest babies. They argue that safer options, such as donor human milk and human-milk-based products, were available. The Judicial Panel's centralization order describes the shared allegation as a higher propensity to cause NEC than allegedly safer alternatives.
Scientific support is the contested point. Keller Postman points to a randomized study of 926 preterm infants, published in The Lancet in 1990, in which NEC was six to ten times more common in babies fed only cow's milk formula than in babies fed only breast milk. The defendants say the science does not show that their products cause NEC, and causation remains the central dispute in the litigation.
What Injuries Are Included in the Baby Formula NEC Lawsuit?
The injuries included in the Baby Formula NEC lawsuit fall into four categories that plaintiffs often plead together. Each is defined in plain language first, followed by what plaintiffs allege. Abbott and Mead Johnson deny that their products cause any of these injuries, and no court has issued a ruling that applies to every family.
Necrotizing Enterocolitis
Necrotizing enterocolitis is a condition in which the lining of the intestine becomes inflamed and tissue in the bowel wall can die.
Plaintiffs allege that feeding cow's milk-based Similac or Enfamil preterm products led to NEC in babies born early. Symptoms listed by plaintiffs' firms include a swollen belly, trouble feeding, bloody stool and vomiting. Doctors often confirm the diagnosis with an abdominal X-ray. Plaintiffs say the disease can progress from feeding trouble to a life-threatening infection within hours.
Short Bowel Syndrome and Bowel Surgery
Short bowel syndrome is a condition in which too little working intestine remains to absorb enough nutrients from food.
Many babies with NEC need surgery to remove dead sections of intestine. Plaintiffs allege that this surgery can leave lifelong feeding and digestion problems, including short bowel syndrome, and repeated hospital stays. Which families can claim these injuries depends on the child's own surgical and medical records.
Neurological and Developmental Problems
Neurodevelopmental problems are difficulties with learning, movement or thinking that begin in early childhood.
Plaintiffs' firms allege that NEC and its treatment are linked to later problems ranging from learning disabilities to cerebral palsy in some surviving children. These claims turn on expert medical opinion about each child's history, since premature birth carries its own developmental risks.
Wrongful Death
Wrongful death is a legal claim that lets certain family members seek damages when a person dies because of another party's alleged wrongdoing.
Several of the best-known cases involve babies who died after developing NEC, including the Watson state-court trial and the federal Inman bellwether. Plaintiffs' firms say about a quarter of infants diagnosed with NEC die. Who may bring a wrongful death claim, and the deadline to do so, depends on state law.
Who Qualifies for the Baby Formula NEC Lawsuit?
You may qualify if:
- Your child was born prematurely, and plaintiffs' firms generally focus on babies born before 37 weeks or at a low birth weight
- Your child was fed a cow's milk-based preterm formula or fortifier, such as a Similac or Enfamil product, in the hospital or at home
- A doctor diagnosed your child with NEC, sometimes described as dead bowel, or your child died after an NEC diagnosis
- Your child's medical records show the formula feeding and the NEC diagnosis
You may not qualify if:
- Your child was never diagnosed with NEC
- Your child received only breast milk or donor human milk and no cow's milk-based formula or fortifier
- Your claim was already resolved, for example through one of the agreements Abbott announced on August 20, 2026
- Your state's statute of limitations has already run, which only an attorney reviewing your dates can determine
Eligibility depends on the specific product, your child's medical records and your state's deadlines. Only a qualified attorney reviewing your records can confirm whether you have a claim in the Baby Formula NEC lawsuit.
What Is the Current Status of the Baby Formula NEC Lawsuits?
The current status of the Baby Formula NEC lawsuits is split between a federal docket that has mostly favored the defendants and state courts that have produced both large plaintiff verdicts and reversals. No global settlement exists as of October 30, 2026.
In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation, MDL No. 3026
MDL No. 3026 is the federal docket in the Northern District of Illinois before Judge Rebecca R. Pallmeyer. The Judicial Panel on Multidistrict Litigation counted 844 pending cases on October 1, 2026, out of 1,064 filed since the MDL began.
Judge Pallmeyer granted Abbott summary judgment in the first three federal bellwether cases, and the Seventh Circuit affirmed the first of those rulings on July 24, 2026. The fourth bellwether, Inman v. Mead Johnson, went to trial in August 2026, and a unanimous federal jury found for Mead Johnson on August 31, 2026.
| Proceeding Type | Federal multidistrict litigation, 28 U.S.C. § 1407 |
| Court | U.S. District Court, Northern District of Illinois |
| Judge | Rebecca R. Pallmeyer |
| Centralized | April 8, 2022 (Transfer Order, Document 119) |
| Pending Cases (Oct. 1, 2025) | 761 of 898 filed |
| Pending Cases (May 1, 2026) | 797 of 987 filed |
| Pending Cases (Oct. 1, 2026) | 844 of 1,064 filed |
| Defendants | Abbott Laboratories (Similac) and Mead Johnson (Enfamil) |
A bellwether result decides only one family's case. Neither the defense wins nor the state-court verdicts bind the other pending claims, so none of them predicts what an individual case is worth.
State-Court Cases in Illinois and Missouri
State courts in Illinois and Missouri have tried NEC formula cases separately from the federal MDL, and the results have swung both ways. Plaintiffs won large verdicts against both companies, and appeals courts and later juries have since reversed or rejected some of them.
| Gill v. Abbott (Missouri) | $495 million verdict for the plaintiff in July 2024, affirmed on appeal in May 2026 and then resolved through Abbott's August 2026 agreements |
| Cook County, Illinois (four families) | $53 million in compensatory damages on April 9, 2026 and $17 million in punitive damages on April 10, 2026 against Abbott, as reported by the plaintiffs' firms and trade press |
| Watson v. Mead Johnson (St. Clair County, Illinois) | $60 million verdict on March 14, 2024, reversed with a new trial ordered by the Illinois Appellate Court, Fifth District, in June 2026 |
| Collins and Whitfield (Missouri) | Defense verdicts for Mead Johnson, according to the company |
Did Abbott Settle the Baby Formula NEC Lawsuits?
Yes, in part. On August 20, 2026, Abbott entered agreements to pay about $670 million to resolve the Gill lawsuit and NEC claims for about 2,000 additional infants, according to the company's SEC filing, and it says the agreements are a compromise of disputed claims and not an admission of liability.
No single payout applies to every family. Outcomes depend on the product, the child's medical records, state law and the proceeding, and only a qualified attorney reviewing your records can estimate what a specific claim may be worth.
The agreements are not a global settlement of the Baby Formula NEC lawsuits. Abbott's filing says about 1,700 lawsuits on behalf of about 12,700 infants remain pending in federal and state courts. The filing describes only Abbott's agreements, and no comparable settlement by Mead Johnson has been announced.
The portion of the $670 million that goes to any one family has not been disclosed, so no per-claimant payout figure exists. Jury verdicts are also not a guide to settlement value, since the Watson verdict was reversed and the Inman jury found for the defense.
No date has been set for a settlement of the remaining cases. Abbott says it continues to work to identify and eliminate such claims.
Latest Baby Formula NEC Lawsuit Updates
This Baby Formula NEC lawsuit update tracks the federal MDL and the main state-court cases as of October 30, 2026. MDL No. 3026 has 844 pending cases, Abbott announced a partial settlement in August, and the timeline below lists every verified event in date order, newest first.
Full Baby Formula NEC Lawsuit Timeline
MDL 3026 Pending Count Dips to 844 Cases
The Judicial Panel on Multidistrict Litigation's October 1, 2026 report listed 844 pending actions in MDL No. 3026 out of 1,064 filed, three fewer pending than a month earlier.
Federal NEC Docket Reaches 847 Pending Cases
As of September 1, 2026, the Judicial Panel counted 847 pending cases in MDL No. 3026 and 1,057 filed in total, the high point of the published monthly counts so far.
Federal Jury Finds for Mead Johnson in First MDL Trial
A unanimous federal jury in the Northern District of Illinois found for Mead Johnson in Inman v. Mead Johnson on August 31, 2026, the first MDL No. 3026 bellwether to reach a jury. Mead Johnson said the science does not support the claims and that no jury verdicts remain outstanding against it in the NEC litigation.
Abbott Agrees to Pay About $670 Million to Resolve NEC Claims
Abbott Laboratories entered agreements on August 20, 2026 to pay about $670 million in total to resolve the Gill verdict and NEC claims for about 2,000 additional infants. Abbott's filing says about 1,700 lawsuits for about 12,700 infants remain pending and that the agreements are not an admission of liability.
Seventh Circuit Affirms Summary Judgment for Abbott
The U.S. Court of Appeals for the Seventh Circuit affirmed summary judgment for Abbott in In re Abbott Laboratories, No. 25-2587, on July 24, 2026, finding that the plaintiff did not show that a different warning would have prevented her daughter's death.
Pending MDL 3026 Cases Climb to 810
The Judicial Panel's July 1, 2026 report listed 810 pending cases and 1,016 filed in MDL No. 3026.
Illinois Appeals Court Reverses $60 Million Watson Verdict
The Illinois Appellate Court, Fifth District, reversed the $60 million verdict against Mead Johnson in Watson and ordered a new trial, according to trade press, which reasoned that the trial court erred on the learned intermediary doctrine. Reuters reported the ruling on June 15, 2026, and some outlets date the decision June 12.
MDL 3026 Holds Near 800 Pending Cases
On June 1, 2026, the Judicial Panel counted 798 pending cases and 1,002 filed in MDL No. 3026, the first time the filed total passed 1,000.
Missouri Appeals Court Affirms the Gill Verdict
A litigation tracker dates the Missouri Court of Appeals decision affirming the $495 million Gill verdict against Abbott to May 5, 2026, and Abbott's SEC filing confirms the affirmance in May 2026. Abbott later chose to settle rather than continue appealing.
Federal Count Reaches 797 Pending Cases
The Panel's May 1, 2026 report showed 797 pending and 987 filed cases in MDL No. 3026.
Cook County Jury Adds $17 Million in Punitive Damages Against Abbott
A Cook County, Illinois jury awarded four families $53 million in compensatory damages on April 9, 2026 and $17 million in punitive damages on April 10, for a combined $70 million against Abbott over Similac preterm products, according to plaintiffs' firms and trade press. Abbott denies that its products cause NEC.
MDL 3026 Lists 782 Pending Cases
As of April 1, 2026, MDL No. 3026 had 782 pending cases among 972 filed, according to the Judicial Panel's monthly report.
Pending Federal Cases Ease to 755
The Judicial Panel's November 3, 2025 report listed 755 pending and 919 filed cases in MDL No. 3026, slightly fewer pending than in October.
Abbott Wins Third Federal Bellwether on Summary Judgment
Drugwatch reported on October 27, 2025 that Judge Pallmeyer had granted Abbott summary judgment in the third federal NEC bellwether case, following two earlier rulings for Abbott.
MDL 3026 Stands at 761 Pending Cases
On October 1, 2025, the Panel counted 761 pending cases and 898 filed in MDL No. 3026.
Federal Docket Grows to 744 Pending Cases
The July 1, 2025 report listed 744 pending and 864 filed cases in MDL No. 3026.
Pending Count Reaches 683
The Panel's April 1, 2025 report put MDL No. 3026 at 683 pending and 790 filed cases.
MDL 3026 Begins 2025 With 632 Pending Cases
As of January 2, 2025, the Judicial Panel counted 632 pending cases and 732 filed in MDL No. 3026.
Pending Federal Cases Total 598
The Panel's October 1, 2024 report listed 598 pending and 673 filed cases in MDL No. 3026.
Missouri Jury Awards $495 Million Against Abbott in Gill
A Missouri state-court jury returned a $495 million verdict against Abbott in the Gill case in July 2024, according to Abbott's SEC filing. Abbott appealed in December 2024.
MDL 3026 Counts 453 Pending Cases
The Judicial Panel's April 1, 2024 report listed 453 pending and 518 filed cases in MDL No. 3026.
St. Clair County Jury Awards $60 Million in Watson
A unanimous St. Clair County, Illinois jury awarded $60 million against Mead Johnson on March 14, 2024 in the first trial over cow's milk-based formula and NEC, according to plaintiffs' firm Keller Postman. The verdict was later reversed on appeal.
Panel Transfers a Hospital-Defendant Case Into the MDL
On October 7, 2022, the Judicial Panel on Multidistrict Litigation transferred the George action, which named a hospital, into MDL No. 3026 as a tag-along case, noting that it shared common questions about causation and the adequacy of warnings to physicians.
Judicial Panel Creates MDL No. 3026 in Chicago
The Judicial Panel on Multidistrict Litigation centralized the preterm infant formula cases in the Northern District of Illinois on April 8, 2022, assigned them to Judge Rebecca R. Pallmeyer, and rejected Abbott's request for the District of Connecticut.
How to File a Baby Formula NEC Lawsuit
Filing a Baby Formula NEC lawsuit generally involves the 6 steps outlined below.
- Confirm the diagnosis and feeding history: A claim generally needs a documented NEC diagnosis and records showing your baby received a cow's milk-based formula or fortifier.
- Gather hospital and NICU records: Request the full chart, including feeding orders, surgical reports, pathology results and discharge summaries, from every hospital that treated your baby.
- Note the product and the dates: Write down which Similac or Enfamil product was used, where it was given and when, because the defendant and the court depend on those facts.
- Check your state's filing deadline: Statutes of limitations differ by state and may be tolled for minors, so a deadline can be shorter or longer than expected.
- Consult a mass-tort attorney: An attorney can review the records, decide whether a claim belongs in the federal MDL or a state court and explain fees before you agree to anything.
- File your case: Your attorney files a complaint in the appropriate court, and federal filings are generally transferred into MDL No. 3026 in Chicago.
Answer a few questions and a case reviewer will follow up. Free, no obligation.
A case reviewer will follow up soon.
What Evidence Do I Need for a Baby Formula NEC Lawsuit?
The evidence you need for a Baby Formula NEC lawsuit is medical and feeding records that show your baby was fed a cow's milk-based formula or fortifier and was then diagnosed with NEC. That usually means the NICU feeding record, the diagnosis and the pathology or imaging reports.
Product details also matter. Hospital administration records, formula labels, receipts for formula used after discharge and the dates of each feeding help show which company's product was involved. In a wrongful death claim, the death certificate and autopsy report, if one exists, carry the most weight.
Expert opinion on causation usually decides the case, because the defendants dispute that formula causes NEC. Only a qualified attorney can say which records a specific claim needs.
What Did Abbott and Mead Johnson Allegedly Know About Baby Formula NEC Risks?
Abbott and Mead Johnson allegedly knew for years that cow's milk-based preterm products carried an NEC risk and did not warn parents or doctors, according to plaintiffs in the Baby Formula NEC lawsuit. Both companies deny this and say their products are safe and essential for premature babies.
Plaintiffs point to published research linking formula feeding to higher NEC rates and argue the companies kept promoting products as equivalent to breast milk. The key legal fight is about warnings: federal and state courts have focused on whether a different warning to doctors would have changed how a particular baby was fed.
Abbott says its August 2026 agreements are not an admission of liability, and Mead Johnson says it rejects any claim that its products cause NEC. The verdicts and rulings summarized above show how courts have treated these arguments so far.
How Does the Baby Formula NEC Lawsuit Compare to Related Cases?
The Baby Formula NEC lawsuit compares to related infant-nutrition cases mainly by product and by the injury alleged, since several unrelated dockets name infant food or formula makers. A plain label for each avoids confusing them.
The Judicial Panel's October 1, 2026 report lists each of the cases below as its own multidistrict litigation, and none of them is part of MDL No. 3026.
| Case | What It's About | Pending Cases (Oct. 1, 2026) |
|---|---|---|
| MDL No. 3026, Preterm Infant Nutrition Products | NEC in premature babies allegedly caused by Similac and Enfamil preterm formula | 844 |
| MDL No. 3037, Recalled Abbott Infant Formula Products | Claims over recalled Abbott infant formula products, before Judge Matthew F. Kennelly in the Northern District of Illinois | 5 |
| MDL No. 3101, Baby Food Products Liability Litigation | Baby food claims in the Northern District of California before Judge Jacqueline Scott Corley | 497 |
| MDL No. 3178, ByHeart Infant Formula | Marketing, sales practices and product liability claims over ByHeart infant formula | 22 |
Frequently Asked Questions
What is the Baby Formula NEC lawsuit about?
The Baby Formula NEC lawsuit is a group of federal and state cases alleging that cow's milk-based preterm formula and fortifier from Abbott (Similac) and Mead Johnson (Enfamil) caused necrotizing enterocolitis in premature babies. Both companies deny that their products cause NEC, and the central dispute is causation and whether the warnings were adequate.
Is the Baby Formula NEC lawsuit a class action or an MDL?
The federal Baby Formula NEC cases are an MDL, not a class action. MDL No. 3026 sits in the Northern District of Illinois before Judge Rebecca R. Pallmeyer, and each family keeps its own individual case, while many more cases are pending in state courts.
What is the latest Baby Formula NEC lawsuit update?
The latest Baby Formula NEC lawsuit update is that the Judicial Panel counted 844 pending cases in MDL No. 3026 on October 1, 2026, and a federal jury found for Mead Johnson on August 31, 2026. Abbott agreed on August 20, 2026 to resolve a group of claims for about $670 million, and no global settlement exists.
Has Abbott settled the NEC baby formula lawsuits?
Abbott has settled part of the NEC baby formula lawsuits but not all of them. Its August 20, 2026 agreements total about $670 million, cover the Gill lawsuit and about 2,000 additional infants, and leave about 1,700 lawsuits for about 12,700 infants pending according to the company's filing.
Can I still file a Baby Formula NEC lawsuit?
You may still be able to file a Baby Formula NEC lawsuit, but it depends on your child's diagnosis, the product used and your state's statute of limitations. Plaintiffs' firms say they are still reviewing new cases, and only an attorney can confirm whether a deadline has passed.
Is the NEC lawsuit related to Form 1099-NEC?
No, the NEC lawsuit is not related to Form 1099-NEC. NEC in this lawsuit means necrotizing enterocolitis, a serious bowel disease in premature babies, while Form 1099-NEC is a tax form for nonemployee compensation. Whether a lawsuit settlement is taxable is a question for a tax professional.
Is the NEC lawsuit the same as the Abbott formula recall lawsuit?
No, the NEC lawsuit is a different matter from the Abbott infant formula recall litigation. The recall cases are tracked as MDL No. 3037, while the NEC cases are tracked as MDL No. 3026 and concern preterm formula that has not been recalled.